AI study to lower high potassium quickly in the ER
Part of Hormones & metabolism clinical trials.
This study uses AI to look at your ECG and decide the best time to give treatment for high potassium (levels over 5.5). It aims to find the most effective timing to lower potassium safely in the emergency room.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated in the emergency department
- Your blood potassium level is 5.5 or higher
- You had a standard 12-lead ECG within 1 hour of that potassium test
- You have not received any potassium-lowering treatment before this blood test
- Your doctors plan to start potassium-lowering treatment within 4 hours of the blood test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how safe and effective SZC is for children with high potassium levels (hyperkalaemia) over the short term, and possibly long term. It aims to help lower potassium safely and see whether it works well in different pediatric age groups.
This trial tests if a portable ECG device can help detect high potassium levels early in people with moderate to severe chronic kidney disease. It aims to make monitoring easier without frequent blood tests.
This study compares a lower dose versus a standard dose of insulin and dextrose (sugar water) to treat moderately high potassium levels in emergency department patients. It aims to see if a lower dose works just as well with fewer side effects.
This study tests if a device can accurately measure potassium levels in people with chronic kidney disease. It also uses an iPhone app to monitor patients remotely.
This trial uses an AI program to review ECG heart-tracing data collected from short-term monitoring devices. It aims to see whether the AI can better detect concerning heart rhythm patterns in people who are high risk for heart rhythm or heart problems.
This study looks at how common high potassium levels are in people with chronic kidney disease who are not on dialysis. It may help find who is at risk and how to prevent it.
Hear when a new Hyperkalaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.